Interventional technology firm Medtronic has received clearance from the U.S. Food and Drug Administration (FDA) for its Complete SE (self-expanding) biliary stent system, the Minneapolis-based firm reported.
The system is designed for use in the palliative treatment of cancers in the bile duct that can compromise digestion. U.S. sales will begin immediately, and the system will be available in various sizes, with diameters of 4 mm to 10 mm and lengths of 20 mm to 150 mm, Medtronic said.
Related Reading
Medtronic nets CE Mark, October 23, 2007
Medtronic's Endeavor moves closer to clearance, October 11, 2007
Medtronic launches CareLink in Europe, August 30, 2007
Medtronic names new CEO, COO, August 24, 2007
Medtronic to buy Biophan MRI technology, August 9, 2007
Copyright © 2007 AuntMinnie.com